Compass Wealth Management LLC Takes Position in SPDR S&P Biotech ETF $XBI

Compass Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 11,499 shares of the exchange traded fund’s stock, valued at approximately $1,167,000.

Several other large investors have also recently added to or reduced their stakes in XBI. NewEdge Wealth LLC boosted its holdings in SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. NewEdge Wealth LLC now owns 3,504 shares of the exchange traded fund’s stock valued at $383,000 after purchasing an additional 188 shares in the last quarter. Essex Financial Services Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 9.0% in the 3rd quarter. Essex Financial Services Inc. now owns 4,502 shares of the exchange traded fund’s stock valued at $451,000 after buying an additional 373 shares during the period. Syon Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 9.4% in the third quarter. Syon Capital LLC now owns 18,608 shares of the exchange traded fund’s stock valued at $1,865,000 after buying an additional 1,604 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock valued at $1,356,582,000 after buying an additional 2,900,633 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its holdings in SPDR S&P Biotech ETF by 60.9% during the third quarter. PNC Financial Services Group Inc. now owns 70,527 shares of the exchange traded fund’s stock worth $7,067,000 after acquiring an additional 26,705 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $126.74 on Friday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $132.09. The stock has a fifty day moving average price of $124.62 and a two-hundred day moving average price of $110.82. The stock has a market capitalization of $8.47 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.